Calf Augmentation in Connecticut
Calf Augmentation in Connecticut section, includes general infrmation about Calf Augmentation Procedure, Calf Augmentation Connecticut Local News, Calf Augmentation Connecticut Surgeon Locator and other Calf Augmentation related material.
Calf Augmentation Procedure
This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.
This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.
Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.
After the surgery you may feel some degree of pain. Your doctor'll subscribe you for painkillers. At the first two days you'll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you'll fell like you're calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You'll be able to go back to work after 7-10 days. You'll get detailed instructions from you're surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.
Other Calf Augmentation Procedures
All Body Procedures
Calf Augmentation Connecticut (current)
Calf Augmentation Connecticut Buttock Augmentation
Calf Augmentation Connecticut Bariatric surgery
Calf Augmentation Connecticut Liposuction
Calf Augmentation Connecticut Body Contouring
More Connecticut info...
Plastic Surgery News...
- The health care reform legislation (ABX1 1) crafted by California Gov. Arnold Schwarzenegger (R) and state General Assembly Speaker Fabian Nunez (D) is "likely to die quietly" in a Senate Health Committee hearing on Monday, "barring a dramatic intervention" from state Senate Pro Tempore Don Perata (D), the San Francisco Chronicle reports (Chorneau, San Francisco Chronicle, 1/28).
- Listed below are the topics that the Department of Health is minded to refer to NICE as the 17th and 18th wave of technology appraisals:
a) 17th wave:
• Advanced hepatocellular carcinoma – sorafenib
• Acute lymphoblastic leukaemia – dasatinib
• Acute lymphoblastic leukaemia – nilotinib
• Thrombocytopenic purpura – eltrombopag
• Thrombocytopenic purpura – AMG 531
• Juvenile idiopathic arthritis – abatacept
• Hepatitis B – tenofovir
• Alzheimer’s disease – xaliproden
• Acute coronary artery syndromes – prasugrel
• Type 1 diabetes – insulin detemir
• Advanced and metastatic melanoma – temozolomide
• Liposomal muramyl tripeptide phosphatidyl ethanolamine as an addition to adjuvant chemotherapy for newly diagnosed, non-metastatic, resectable osteosarcoma
• Chronic myeloid leukaemia – dasatinib and nilotinib
• Relapsed small cell lung cancer – topotecan
• Polyarticular juvenile idiopathic arthritis – adalimumab and etanercept
• Venous thromboembolism – rivaroxaban
For further details and links to the draft scope documents, please see the link above.
b) 18th wave
• Bortezomib for multiple myeloma
Sunitinib for gastrointestinal stromal tumours
• Topotecan for cervical cancer
• Trabectedin for soft tissue sarcoma
• Ustekinumab for moderate to severe psoriasis
• Tocilizumab for rheumatoid arthritis
• Pemetrexed for non small cell lung cancer
• Rituximab for lymphocytic leukaemia
• Azacitidine for high risk patients with myelodysplastic syndrome and acute myeloid leukaemia
• Oral alitretinoin for severe chronic hand eczema
• Capecitabine for gastric cancer
• Methylnatrexone for opioid-induced bowel dysfunction